Implementation of personalized medicine in a context of moral hazard and uncertainty about treatment efficacy
Year of publication: |
2021
|
---|---|
Authors: | Alcenat, Stéphane ; Maréchal, François ; Naegelen, Florence |
Published in: |
International journal of health economics and management. - New York, NY : Springer, ISSN 2199-9031, ZDB-ID 2817492-6. - Vol. 21.2021, 1, p. 81-97
|
Subject: | Genetic information | Healthcare | Moral hazard | Optimal contracts | Personalized medicine | Pharmacoeconomics | Moral Hazard | Arzneimittel | Pharmaceuticals | Theorie | Theory | Medizinische Behandlung | Medical treatment | Prinzipal-Agent-Theorie | Agency theory | Krankenversicherung | Health insurance | Gesundheitsversorgung | Health care | Risiko | Risk |
-
Contracts to promote optimal use of optional diagnostic tests in cancer treatment
Ghamat, Salar, (2018)
-
Outcomes-based reimbursement policies for chronic care pathways
Zorc, Sasa, (2017)
-
Outcomes-based reimbursement policies for chronic care pathways
Zorc, Sasa, (2023)
- More ...
-
Naegelen, Florence, (1988)
-
La malédiction du vainqueur dans les procédures d'appel d'offres
Naegelen, Florence, (1986)
-
L' attribution des marchés en fonction de l'offre économiquement la plus avantageuse
Naegelen, Florence, (1998)
- More ...